Abstract
Anterior proliferative vitreoretinopathy (PVR) is the greatest challenge facing the surgeon attempting to repair recurrent retinal detachment [1]. The Retina Society recognized this and, to create a more prognostic classification, added anterior proliferation and posterior proliferation (extensive macular pucker) to its ABCD classification of PVR [2] (Figure V.B.6-1). The traction forces at the vitreous base were classified as circumferential or anterior (Figure V.B.6-2), acknowledging the complexity of contraction of fibrous tissue formation in this zone. Machemer first described retinotomy in 1981 [3] for incarcerated retina in a ruptured globe. Zivonovich described its application for severe traction membranes [4]. Subsequent reports followed [5–9] and emphasized the importance of removing retina anterior to the retinotomy to prevent re-proliferation, extending the retinotomy to an adequate size, the importance of long-term tamponade, and the benefit of perfluorocarbon liquids. In the PVR Silicone Oil Study, retinotomy was performed in 29 % of cases [10].
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
FormalPara Key Concepts-
1.
Anterior PVR membranes transmit traction to the retina and ciliary body via the arcuate fibers of the vitreous base, the “anterior loop”.
-
2.
The firm adhesion of vitreous to peripheral retina makes it impossible to surgically separate the two structures.
-
3.
Retinectomy is currently the treatment of choice for severe anterior PVR, although the future may see pharmacologic vitreolysis as adjunctive therapy to decrease vitreoretinal adhesion and facilitate removal of vitreous and PVR membranes.
I. Introduction
Anterior proliferative vitreoretinopathy (PVR) is the greatest challenge facing the surgeon attempting to repair recurrent retinal detachment [1]. The Retina Society recognized this and, to create a more prognostic classification, added anterior proliferation distinct from posterior proliferation (extensive macular pucker) to its ABCD classification of PVR [2] (Table V.B.6-1). The traction forces at the vitreous base were classified as circumferential or anterior (Figure V.B.6-1), acknowledging the complexity of contraction of fibrous tissue formation in this zone. Machemer first described retinotomy in 1981 [3] for incarcerated retina in a ruptured globe. Zivonovich described its application for severe traction membranes [4]. Subsequent reports followed [5–9] and emphasized the importance of removing retina anterior to the retinotomy to prevent re-proliferation, extending the retinotomy to an adequate size, the importance of long-term tamponade, and the benefit of perfluorocarbon liquids. In the PVR Silicone Oil Study, retinotomy was performed in 29 % of cases [10].
II. Pathophysiology
The cellular aspects of PVR pathogenesis are discussed in chapter III.J. Cell proliferation at the vitreoretinal interface in PVR and related disorders. It is important to appreciate that the proliferation of cells and formation of PVR membranes are influenced by the underlying structures of the vitreous cortex (see chapter II.E. Vitreoretinal interface and ILM) that creates surfaces upon which membranes form. The orientation of collagen fibrils within the vitreous base influences the vector of forces generated by contracting PVR membranes. The Retina Society classification of anterior traction being “circumferential” or “anterior” reflects the fact that the underlying structure of the vitreous base is an important component of the phenomenon. (see Table V.B.6-1) Circumferential traction arises from the entire vitreous base, a three-dimensional doughnut-like structure that straddles the ora serrata 360°. Within the vitreous base is a dense network of collagen fibrils that insert anterior and posterior to the ora serrata (Figure V.B.6-1). Because of the strong adherence of the vitreous to the retina in this area [11, 12], it is impossible to detach the vitreous at the vitreous base. Therefore, it is impossible to peel membranes in this area.
The collagen fibers of the vitreous base form a loop, called the “anterior loop” which connects the peripheral retina and the pars plana of the ciliary body (Figure V.B.6-2). Contraction of PVR membranes in the peripheral anterior vitreous thus transmits traction to adjacent structures. When the ciliary body detaches, it ceases to synthesize the aqueous and the result is hypotony. If traction is extensive, there can even be iris retraction. Perpendicular traction mediated by the anterior loop (Figure V.B.6-2) rolls the anterior retina forward onto the pars plana and foreshortens the retina usually inferiorly where retinal pigment epithelial cells preferentially settle and proliferate. For this reason, the retina can detach posterior to a broad and high inferior scleral buckle. Retinal reattachment rates improved when removal of crystalline lenses improved access to the vitreous base, and techniques were developed to better visualize this zone and to dissect membranes in this area thereby freeing up foreshortened retina.
III. Surgical Approach
In many cases, the retina remains foreshortened even after aggressive dissection, and the retina must be cut to allow the posterior retina to settle.
A. Retinotomy and Retinopexy
The location of the retinotomy should be posterior to all present and future contraction and therefore posterior to the vitreous base. Panoramic viewing systems provide an excellent view of the peripheral retina for this purpose. In the presence of a scleral buckle, the retinotomy can be made over the buckle posterior to the vitreous base, but if the retina is adherent over the buckle because of extensive retinopexy, then the retinotomy is made just posterior to the buckle. The extent of the retinotomy should allow complete relaxation of the inferior retina. An inferior 180° retinotomy is most common. Failure often occurs at the end of the retinotomy, and a 180° retinotomy places the ends more superiorly where there is less risk of re-proliferation and where there is superior tamponade especially with gas. Most relaxing retinotomies are circumferential, but occasionally a radial retinotomy may be indicated in cases of severe posterior foreshortening.
Prophylactic intraocular diathermy is applied to the area that will be cut to prevent bleeding and accumulation underneath the macula. The retina can be cut with scissors, but small incision high-speed vitreous cutters give superior control and safety (Figure V.B.6-4). For a more detailed discussion of the advantages of small incision high-speed vitreous cutters, see chapter V.B.2. Modern vitrectomy cutters. The vitreous can be cut in either a fluid-filled eye or a tamponade-filled eye. The latter is more common in a reoperation. The advantage of cutting in a fluid-filled eye is that traction is more easily evaluated so the proper location and extent of the retinotomy can be optimized. Under oil, the retina can look artificially fine, even though there may be significant traction present. This occult inferior shortening of the retina manifests itself as recurrent retinal detachment after the oil is removed. An advantage of operating through tamponade is that the retina reattaches nicely as the retinotomy is performed, confirming that traction is relieved. However, any bleeding that may occur from inadequate prophylactic diathermy is trapped under the tamponade and requires that the tamponade be removed and the blood washed out. Blood trapped between the oil and retina induces re-proliferation, and the blood trapped between the gas and retina eventually diffuses into the vitreous chamber as the gas absorbs preventing postoperative evaluation of the retina. A successful inferior relaxing retinotomy should have good laser reaction around the margins and minimal fibrous re-proliferation and an attached retina.
B. Vitreous Substitutes
Perfluorocarbon liquid is used to reattach the retina. Laser retinopexy can be administered through the perfluorocarbon liquid or after a subsequent gas-fluid exchange. The view to the periphery through a panoramic viewing system is expanded under gas which facilitates laser retinopexy. A directional laser probe is very useful in lasering the peripheral retinotomy. Laser retinopexy is preferred over cryoretinopexy because it has less effects on the blood-retinal barrier. The perfluorocarbon liquid (Figure V.B.6-5) is then removed and replaced with the final tamponade. Posterior slippage of the posterior edge of the retinotomy can occur at this point of the procedure. This is minimized by removing first all the irrigation fluid anterior to the perfluorocarbon liquid and then removing all subretinal fluid at the edges of the retinotomy before perfluorocarbon liquid posterior to the retinotomy (Figure V.B.6-6) is exchanged for air or oil.
Long-term tamponade can be provided by perfluoropropane gas or silicone oil. Silicone oil may be preferable because it can provide tamponade for several months outlasting the self-limited duration of PVR cellular activity but at the risk of perisilicone oil proliferation. Posterior slippage of the retinotomy which develops during direct exchange of perfluorocarbon liquid for silicone oil is caused by the small amount of infusion fluid trapped anterior to the sclerotomies when perfluorocarbon liquid is infused and the infusion line is open [13] (Figure V.B.6-7). This fluid allows the retinotomy edge to slip posteriorly at the conclusion of the oil fill (Figure V.B.6-8). This is avoided by turning off the infusion and then filling the eye completely with perfluorocarbon liquid, pushing any remaining fluid out through a superiorly positioned sclerotomy and making sure the perfluorocarbon liquid is seen in the infusion line. The perfluorocarbon liquid pushes the irrigation fluid anterior to the sclerotomies out through the open infusion line (Figure V.B.6-9). Postoperative positioning with oil is minimized when there is a good oil fill. Adequate tamponade with gas because of its diminishing volume may require alternating lateral sides or even a supine positioning. An inadequate gas bubble should be remedied on the first postoperative day by a gas-fluid exchange in the clinic. Oil is removed at 6 months when cellular activity of proliferative vitreoretinopathy is minimal. At the time of oil removal, the retina is examined carefully and prophylactic laser retinopexy or membrane peeling may be indicated (Figure V.B.6-10).
C. Complications
Complications include retained subfoveal perfluorocarbon, macular pucker, hypotony, macular displacement, PVR re-proliferation at the retinotomy edges, corneal decompensation, emulsified silicone oil with or without glaucoma, and iris neovascularization. Retained perfluorocarbon liquid can be aspirated with a 39-gauge cannula [14] or displaced by injection of subretinal fluid and upright positioning. As discussed above, macular pucker is a risk of silicone oil tamponade and is addressed by repeat vitrectomy and membrane peeling. Internal limiting membrane peeling may prevent recurrences. Corneal decompensation is caused by oil migrating into the anterior chamber [15, 16]. Decreased aqueous production caused by PVR fibrosis of the ciliary body also contributes to corneal decompensation [17]. Emulsified oil, previously thought to be due to impurities in the oil, is now thought to be caused by emulsifiers in the oil such as blood and protein [18]. Therefore, preventing hemorrhage during retinotomy is important. Iris neovascularization is caused by fibrotic organization within the ciliary body and pars plana, and removal of the retina anterior to the retinotomy prevents this and consequent hypotony.
IV. Future Developments
A. Surgical
Twenty-seven-gauge vitrectomy instrumentation may be ideal for performing relaxing retinotomy. The inefficiency of such small-gauge instrumentation does not matter since the vitreous has already been removed. On the other hand, the precision and ability of the cutting port to be closer to the retinal pigment epithelium during the retinotomy should be an advantage [19]. There are significant challenges to the application of femtosecond laser to the posterior segment compared to its use in the anterior segment. However, the photodisruptive properties of femtosecond laser could be harnessed for the cutting of the retina [see chapter V.B.3. Future vitrectomy technologies].
B. Pharmacologic
Pharmacologic vitreolysis [see chapter VI.A. Pharmacologic vitreolysis] may provide useful adjuncts to surgery of anterior PVR by weakening the very strong vitreoretinal adhesion at the vitreous base. Indeed, studies in monkeys employing chondroitinase to perform pharmacologic vitreolysis found disinsertion of the vitreous base [see chapter VI.H. Chondroitinase as a vitreous interfactant – vitreous disinsertion in the human].
- PVR:
-
proliferative vitreoretinopathy
- ILM:
-
inner limiting membrane
- L:
-
lens
References
Lewis H, Aaberg TM. Anterior proliferative vitreoretinopathy. Am J Ophthalmol. 1988;105:277–84.
Machemer R, Aaberg TM, Freeman HJM, et al. Updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112:159–65.
Machemer R. Retinotomy. Am J Ophthalmol. 1981;92(6):768–74.
Zivojnovic R. Silicone Oil in Vitreo-retinal Surgery. Dardrecht: Martinus Nidjhoff Publishers; 1967. p. 142–3.
Han D, et al. Relaxing retinotomy and retinectomy: surgical results and predeterming visual outcomes. Arch Ophthalmol. 1990;108(5):694–7.
Morse L, McCuen BM, Machemer R. Relaxing retinotomy: analysis of anatomic and visual results. Ophthalmology. 1990;97(5):643–7.
Iverson DA, et al. Indications and results of relaxing retinotomy. Ophthalmology. 1990;97(10):1298–304.
Federman J, Eagle R. Extensive peripheral retinectomy combined with posterior 360 degree retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy. Ophthalmology. 1990;97(10):1305–20.
Han DP, et al. Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection. Am J Ophthalmol. 1994;118(1):24–32.
Blumenkrantz M, et al. Relaxing retinotomy with silicone oil or long acting gas with severe proliferative vitreo retinopathy: Silicone Study report 5. The Silicone Study Group. Am J Ophthalmol. 1993;116(5):557–64.
Hogan MJ. The vitreous. Its structure in relation to the ciliary body and retina. Invest Ophthalmol. 1963;2:418–45.
Daicker B. Sind die symptom “Weiss mit Druck” und “Weiss ohne Druck” durch die periphere netzhautsklerose bedingt? Mod Probl Ophthalmol. 1975;15:82–90.
Li KK, Wong D. Avoiding retinal slippage during macular translocation surgery with 360 retinotomy. Graefes Arch Clin Exp Ophthalmol. 2008;246:649–51.
Roth DB, Sears JE, Lewis H. Removal of retained subfoveal perfluoro-n-octane liquid. Am J Ophthalmol. 2004;138(2):287–9.
Liesenhoff HH, Schmitt J. Koplikationene durch flussiges silicon in der vorderkammer. Berl Dtsch Ophthalmol Ges. 1969;69:643–4.
Sternberg Jr P, Hatchell DL, Foulks GN, et al. The effect of silicone oil on the cornea. Arch Ophthalmol. 1985;103:90–4.
Zarbin MA, Michels RG, Green WR. Dissection of epiciliary tissue to treat chronic hypotony after surgery for retinal detachment with proliferative vitreoretinopathy. Retina. 1991;11:208–13.
Bartov E, Pennarola F, Savion N, et al. A quantitative in vitro model for silicone oil emulsification. Role of blood constituents. Retina. 1992;12:523–7.
Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology. 2010;117:93–102.
Sebag J, Balazs EA. Pathogenesis of CME – an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol. 1984;28(Suppl):493–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chong, L.P. (2014). V.B.6. Retinectomy for Recalcitrant Retinal Detachments. In: Sebag, J. (eds) Vitreous. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1086-1_43
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1086-1_43
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1085-4
Online ISBN: 978-1-4939-1086-1
eBook Packages: MedicineMedicine (R0)